Ticagrelor Versus Clopidogrel as Dual Antiplatelet Agents After Flow Diversion With Surface-Modified Stents.
BACKGROUND AND OBJECTIVES Dual antiplatelet therapy (DAPT) is an essential component of medical management after flow diversion. To our knowledge, no studies have compared DAPT regimens using ticagrelor vs clopidogrel in patients undergoing flow diversion with newer generation surface-modified stents. Our study compare...